Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Clinical study of RU 23908 (nilutamide) in prostatic cancer].
Akaza H, Aso Y, Niijima T, Fuse H, Izaka S, Akimoto S, Shimazaki J, Imai K, Yamanaka H, Kihara K, et al. Akaza H, et al. Among authors: niijima t. Hinyokika Kiyo. 1991 Apr;37(4):407-20. Hinyokika Kiyo. 1991. PMID: 1892002 Free article. Clinical Trial. Japanese.
[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR].
Niijima T, Aso Y, Akaza H, Fujita K, Fuse H, Hosaka M, Isurugi K, Kamidono S, Katayama T, Kawabe K, et al. Niijima T, et al. Hinyokika Kiyo. 1990 Nov;36(11):1343-60. Hinyokika Kiyo. 1990. PMID: 2126912 Free article. Japanese.
The 4th study of prophylactic intravesical chemotherapy with adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese Urological Cancer Research Group for Adriamycin.
Matsumura Y, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Niijima T, Obata K, Ohashi Y, et al. Matsumura Y, et al. Among authors: niijima t. Cancer Chemother Pharmacol. 1992;30 Suppl:S10-4. doi: 10.1007/BF00686934. Cancer Chemother Pharmacol. 1992. PMID: 1394809 Clinical Trial.
[Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
Niijima T, Akaza H, Koyanagi T, Togashi M, Kumamoto Y, Funyu T, Suzuki T, Orikasa S, Yoshikawa K, Koiso K, et al. Niijima T, et al. Hinyokika Kiyo. 1992 Oct;38(10):1201-7. Hinyokika Kiyo. 1992. PMID: 1481783 Free article. Clinical Trial. Japanese.
208 results